Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin.

@article{Manning1989SolidphaseSO,
  title={Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin.},
  author={M. Manning and M. Kruszynski and K. Bańkowski and A. Olma and B. Lammek and L. Cheng and W. Kliś and J. Seto and J. Haldar and W. H. Sawyer},
  journal={Journal of medicinal chemistry},
  year={1989},
  volume={32 2},
  pages={
          382-91
        }
}
  • M. Manning, M. Kruszynski, +7 authors W. H. Sawyer
  • Published 1989
  • Chemistry, Medicine
  • Journal of medicinal chemistry
  • We describe the synthesis and some pharmacological properties of 16 new in vivo antagonists of oxytocin. These are based on modifications of three peptides: A, B, and C. A is our previously reported potent and selective antagonist of the vasopressor (V1 receptor) responses to arginine-vasopressin (AVP)/weak oxytocin antagonist, [1-(beta-mercapto-beta,beta-pentamethylenepropionic acid), 2-O-methyltyrosine]arginine-vasopressin (d(CH2)5[Tyr(Me)2]AVP. B reported here, the Ile3 analogue of A, is d… CONTINUE READING
    97 Citations
    Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban
    • M. Manning, L. Cheng, +6 authors C. Barberis
    • Chemistry, Medicine
    • Journal of peptide science : an official publication of the European Peptide Society
    • 2005
    • 22
    Discovery of novel selective hypotensive vasopressin peptides that exhibit little or no functional interactions with known oxytocin/vasopressin receptors
    • 16
    Position Three in Vasopressin Antagonist Tolerates Conformationally Restricted and Aromatic Amino Acid Substitutions: A Striking Contrast with Vasopressin Agonists
    • M. Manning, L. Cheng, +6 authors W. Y. Chan
    • Chemistry, Medicine
    • Journal of peptide science : an official publication of the European Peptide Society
    • 1997
    • 20